|Head Office||3-chome-24-5 Shinnyokohama,Kohoku Ward, Yokohama, Kanagawa, 222-0033, Japan|
|company representative||Tokinori Terada|
|Business||R&D of chemical compounds.
Utilization of intellectual properties.
Planning, manufacturing, sales of health food.
|Sep.2022||Chemiteras has been appointed as a brand influencer for Karada Laboratory's BI-HARI, a wholly owned subsidiary of Cross Marketing Group, Inc.(listed on the TSE Prime Market).
■Chemiteras becomes a brand influencer for Karada Laboratory's BI-HARI
|Jun.2022||Chemiteras has signed an agreement for exclusive sales right in Japan with Safely2Prosperity LLC (Headquarters: Massachusetts, USA, Representative Director: John Norris), a leading company that provides cloud-based software as a corporate and organizational management system for next-generation infectious diseases.
■ Chemiteras Inc. and Safely2Prosperity LLC
Signed an Agreement for Exclusive Sales Right in Japan（Japanese only）
Additionally, John Norris, the founder＆CEO of Safely2Prosperity, has been appointed as one of our advisors.
||SIRTUP, a dietary supplement containing deazaflavine, a seed compound for drug discovery based on our patented technology, has been released by Life Science Lab Co.
■SIRTUP Product Overview（Japanese only）
|Oct.2021||Release: News release published in multiple media including PRTIMES
■「Successful development and patent acquisition of a compound showing mitochondrial activity」（Japanese only）
|Sep.2021||“UNIPLAT” was officially launched on September 28, 2021.
|Nov.2020||The online support platform for researchers "UNIPLAT", which we are entrusted with system development, has been published in the Group of Nations, a public relations magazine of the international summits.
■Group of Nations / G20 GLOBAL BRIEFING REPORT 2020
(UNIPLAT is on pages 156 and 157)
This magazine is an official publication for international conferences such as G8, G20, APEC.
|Aug.2019||Signed an advisory agreement with Dr. Torkel Falkenberg, deputy head for Karolinska Institutet Center for Social Sustainability in Sweden.|
Patent applications of a seed compound for the brain cancer drug
Patent application of a seed compound for the mitochondrial related drug
Patent applications of a seed compound for the Hyperuricemia treatment drug